Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.

Takahashi K, Wall SB, Suzuki H, Smith AD 4th, Hall S, Poulsen K, Kilian M, Mobley JA, Julian BA, Mestecky J, Novak J, Renfrow MB.

Mol Cell Proteomics. 2010 Nov;9(11):2545-57. doi: 10.1074/mcp.M110.001834. Epub 2010 Sep 7.

2.

Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.

Franc V, Řehulka P, Raus M, Stulík J, Novak J, Renfrow MB, Šebela M.

J Proteomics. 2013 Oct 30;92:299-312. doi: 10.1016/j.jprot.2013.07.013. Epub 2013 Jul 24.

3.

Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.

Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG, Novak J.

J Biol Chem. 2005 May 13;280(19):19136-45. Epub 2005 Feb 22.

4.

Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy.

Renfrow MB, Mackay CL, Chalmers MJ, Julian BA, Mestecky J, Kilian M, Poulsen K, Emmett MR, Marshall AG, Novak J.

Anal Bioanal Chem. 2007 Nov;389(5):1397-407. Epub 2007 Aug 22.

PMID:
17712550
5.

Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.

Takahashi K, Raska M, Stuchlova Horynova M, Hall SD, Poulsen K, Kilian M, Hiki Y, Yuzawa Y, Moldoveanu Z, Julian BA, Renfrow MB, Novak J.

PLoS One. 2014 Jun 11;9(2):e99026. doi: 10.1371/journal.pone.0099026. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e113577.

6.

Naturally occurring structural isomers in serum IgA1 o-glycosylation.

Takahashi K, Smith AD, Poulsen K, Kilian M, Julian BA, Mestecky J, Novak J, Renfrow MB.

J Proteome Res. 2012 Feb 3;11(2):692-702. doi: 10.1021/pr200608q. Epub 2011 Dec 29.

7.

Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.

Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.

Biochemistry. 2010 Jul 13;49(27):5671-82. doi: 10.1021/bi9019498.

8.

Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.

Gastaldi D, Paradisi L, Baiocchi C, Medana C, Lo Duca G, Sena LM, Roccatello D.

J Nephrol. 2007 Nov-Dec;20(6):689-95.

PMID:
18046671
9.

IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.

Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.

Contrib Nephrol. 2007;157:134-8. Review.

PMID:
17495451
10.

Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K.

Kidney Int. 2001 Mar;59(3):1077-85.

11.

Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy.

Allen AC.

J Nephrol. 1999 Mar-Apr;12(2):76-84. Review.

PMID:
10378662
12.

Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J.

J Clin Invest. 1999 Jul;104(1):73-81.

13.

IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.

Horie A, Hiki Y, Odani H, Yasuda Y, Takahashi M, Kato M, Iwase H, Kobayashi Y, Nakashima I, Maeda K.

Am J Kidney Dis. 2003 Sep;42(3):486-96.

PMID:
12955676
14.

N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.

Stuchlova Horynova M, Vrablikova A, Stewart TJ, Takahashi K, Czernekova L, Yamada K, Suzuki H, Julian BA, Renfrow MB, Novak J, Raska M.

Nephrol Dial Transplant. 2015 Feb;30(2):234-8. doi: 10.1093/ndt/gfu308. Epub 2014 Oct 3.

15.

Heterogeneity of O-glycosylation in the hinge region of human IgA1.

Novak J, Tomana M, Kilian M, Coward L, Kulhavy R, Barnes S, Mestecky J.

Mol Immunol. 2000 Dec;37(17):1047-56.

PMID:
11399322
16.

Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Hiki Y, Tanaka A, Kokubo T, Iwase H, Nishikido J, Hotta K, Kobayashi Y.

J Am Soc Nephrol. 1998 Apr;9(4):577-82.

17.

Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K, Renfrow MB, Novak L, Wyatt RJ, Novak J.

Kidney Blood Press Res. 2008;31(1):29-37. doi: 10.1159/000112922. Epub 2008 Jan 8. Review.

18.

Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.

Odani H, Yamamoto K, Iwayama S, Iwase H, Takasaki A, Takahashi K, Fujita Y, Sugiyama S, Hiki Y.

J Nephrol. 2010 Jan-Feb;23(1):70-6.

PMID:
20091489
19.

IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.

Novak J, Julian BA, Tomana M, Mestecky J.

Semin Nephrol. 2008 Jan;28(1):78-87. doi: 10.1016/j.semnephrol.2007.10.009. Review.

20.

Structural features of IgA molecules which contribute to IgA nephropathy.

Feehally J, Allen AC.

J Nephrol. 1999 Mar-Apr;12(2):59-65. Review.

PMID:
10378660

Supplemental Content

Support Center